(Q43830285)

27 November 2017

title

Elevated systemic monocyte chemoattractrant protein-1 in hepatic steatosis without significant hepatic inflammation (English)

1 reference

27 November 2017

0 references

1 reference

Georgi Kirovski

1

1 reference

27 November 2017

Christoph Dorn

2

1 reference

27 November 2017

Hanna Huber

3

1 reference

27 November 2017

Lukas Moleda

4

1 reference

27 November 2017

Catrin Niessen

5

1 reference

27 November 2017

Hella Wobser

6

1 reference

27 November 2017

Doris Schacherer

7

1 reference

27 November 2017

Christa Buechler

8

1 reference

27 November 2017

Reiner Wiest

9

1 reference

27 November 2017

Claus Hellerbrand

10

1 reference

27 November 2017

publication date

7 August 2011

1 reference

Experimental and Molecular Pathology

27 November 2017

published in

1 reference

27 November 2017

volume

91

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

780-783

1 reference

Nonalcoholic fatty liver disease

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

Epidemiology of non-alcoholic fatty liver disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

Association of monocyte chemoattractant protein-1 with adipocyte number, insulin resistance and liver function markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high-fat diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

Nonalcoholic steatohepatitis and the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

Epidemiology of the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

Immortal activated human hepatic stellate cells generated by ectopic telomerase expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

CCR2 promotes hepatic fibrosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

Expression of CC chemokine ligand 5 in patients with rheumatoid arthritis and its correlation with disease activity and medication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.08.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEXMP.2011.08.001

1 reference

27 November 2017

1 reference